# EDGAR Filing Document

**Accession Number:** 0001209466
**File Stem:** 0001752724-25-161228
**Filing Date:** 2025-6
**Character Count:** 15944
**Document Hash:** 6cd6e1df65924f29d6c2adb36f9b1660
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001752724-25-161228.hdr.sgml**: 20250627

**ACCESSION NUMBER**: 0001752724-25-161228

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20250430

**FILED AS OF DATE**: 20250627

**DATE AS OF CHANGE**: 20250627

**PERIOD START**: 20250430

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** INVESCO EXCHANGE-TRADED FUND TRUST
- **CENTRAL INDEX KEY:** 0001209466

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** MA
- **FISCAL YEAR END:** 0430

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-21265
- **FILM NUMBER:** 251082976

**BUSINESS ADDRESS:**
- **STREET 1:** 3500 LACEY ROAD
- **STREET 2:** SUITE 700
- **CITY:** DOWNERS GROVE
- **STATE:** IL
- **ZIP:** 60515
- **BUSINESS PHONE:** 800-983-0903

**MAIL ADDRESS:**
- **STREET 1:** 3500 LACEY ROAD
- **STREET 2:** SUITE 700
- **CITY:** DOWNERS GROVE
- **STATE:** IL
- **ZIP:** 60515

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** POWERSHARES EXCHANGE TRADED FUND TRUST
- **DATE OF NAME CHANGE:** 20021210

## Series and Classes Contracts Data

### Invesco Pharmaceuticals ETF (Series ID: S000003031)

| Class ID   | Class Name                  | Ticker Symbol   |
|:---|:---|:---|
| C000008298 | Invesco Pharmaceuticals ETF | PJP             |

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** Invesco Exchange-Traded Fund Trust

- **b. Investment Company Act file number:** 811-21265

- **c. CIK number of Registrant:** 0001209466

- **d. LEI of Registrant:** QPT4TMG79RF3UWNU0R52

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 3500 Lacey Road

  - **City:** Downers Grove

  - **State:** IL

  - **Foreign country:** US

  - **Zip / Postal Code:** 60515

  - **Telephone number:** 800-983-0903

**Item A.2. Information about the Series.**

- **a. Name of Series:** Invesco Pharmaceuticals ETF

- **b. EDGAR series identifier (if any):** S000003031

- **c. LEI of Series:** 549300SCARFWCQZS8C10

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2025-04-30

- **b. Date as of which information is reported:** 2025-04-30

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $298660404.92

**Total Liabilities:** $54920454.60

**Net Assets:** $243739950.32

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000008298 | 0.91%                | 0.04%                | -5.23%               |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $989067.55               | $1256511.71                                |
| Month 2  | $273616.26               | $-426351.83                                |
| Month 3  | $637573.72               | $-14742892.29                              |

### Schedule of Portfolio Investments

| Name                                  | Title                                                      | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Collegium Pharmaceutical, Inc.        | Collegium Pharmaceutical, Inc.                             | CUSIP: 19459J104<br>LEI: 54930049FXZMTLW8D496 | Long             | EC               | CORP              | US        |    245226 | NS      | $6619875.87   | 2.72%             |  |  |  | No            |                  1 | On Loan: —       |
| Corcept Therapeutics Inc.             | Corcept Therapeutics Inc.                                  | CUSIP: 218352102<br>LEI: 529900EO9LUTFMZ7FF90 | Long             | EC               | CORP              | US        |    115420 | NS      | $8296389.60   | 3.40%             |  |  |  | No            |                  1 | On Loan: —       |
| Ligand Pharmaceuticals Inc.           | Ligand Pharmaceuticals Inc.                                | CUSIP: 53220K504<br>LEI: 5493008K7TB0IKP37H79 | Long             | EC               | CORP              | US        |     59553 | NS      | $6542492.58   | 2.68%             |  |  |  | No            |                  1 | On Loan: —       |
| Amphastar Pharmaceuticals, Inc.       | Amphastar Pharmaceuticals, Inc.                            | CUSIP: 03209R103<br>LEI: 54930055TH0ZLSAQMJ38 | Long             | EC               | CORP              | US        |    220915 | NS      | $5392535.15   | 2.21%             |  |  |  | No            |                  1 | On Loan: —       |
| Perrigo Co. PLC                       | Perrigo Co. PLC                                            | CUSIP: G97822103<br>LEI: 549300IFOQS6R1QLY196 | Long             | EC               | CORP              | IE        |    280307 | NS      | $7209496.04   | 2.96%             |  |  |  | No            |                  1 | On Loan: —       |
| Eli Lilly and Co.                     | Eli Lilly and Co.                                          | CUSIP: 532457108<br>LEI: FRDRIPF3EKNDJ2CQJL29 | Long             | EC               | CORP              | US        |     14374 | NS      | $12921507.30  | 5.30%             |  |  |  | No            |                  1 | On Loan: No      |
| Bristol-Myers Squibb Co.              | Bristol-Myers Squibb Co.                                   | CUSIP: 110122108<br>LEI: HLYYNH7UQUORYSJQCN42 | Long             | EC               | CORP              | US        |    121412 | NS      | $6094882.40   | 2.50%             |  |  |  | No            |                  1 | On Loan: No      |
| Regeneron Pharmaceuticals, Inc.       | Regeneron Pharmaceuticals, Inc.                            | CUSIP: 75886F107<br>LEI: 549300RCBFWIRX3HYQ56 | Long             | EC               | CORP              | US        |      9771 | NS      | $5850483.96   | 2.40%             |  |  |  | No            |                  1 | On Loan: No      |
| Gilead Sciences, Inc.                 | Gilead Sciences, Inc.                                      | CUSIP: 375558103<br>LEI: 549300WTZWR07K8MNV44 | Long             | EC               | CORP              | US        |    116189 | NS      | $12378776.06  | 5.08%             |  |  |  | No            |                  1 | On Loan: No      |
| Jazz Pharmaceuticals PLC              | Jazz Pharmaceuticals PLC                                   | CUSIP: G50871105<br>LEI: 635400GAUMJCLEZRRV50 | Long             | EC               | CORP              | IE        |     50617 | NS      | $5920164.32   | 2.43%             |  |  |  | No            |                  1 | On Loan: —       |
| Geron Corp.                           | Geron Corp.                                                | CUSIP: 374163103<br>LEI: 549300T282D7Z2YESL90 | Long             | EC               | CORP              | US        |   2981732 | NS      | $4204242.12   | 1.72%             |  |  |  | No            |                  1 | On Loan: —       |
| Prestige Consumer Healthcare Inc.     | Prestige Consumer Healthcare Inc.                          | CUSIP: 74112D101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     80925 | NS      | $6573537.75   | 2.70%             |  |  |  | No            |                  1 | On Loan: —       |
| AbbVie Inc.                           | AbbVie Inc.                                                | CUSIP: 00287Y109<br>LEI: FR5LCKFTG8054YNNRU85 | Long             | EC               | CORP              | US        |     63477 | NS      | $12384362.70  | 5.08%             |  |  |  | No            |                  1 | On Loan: No      |
| OmniAb Operations, Inc.               | OmniAb Operations, Inc., Rts., expiring 2027-11-02         | CUSIP: 68218J301<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     39023 | NS      | $0.00         | 0.00%             |  |  |  | No            |                  3 | On Loan: —       |
| ANI Pharmaceuticals, Inc.             | ANI Pharmaceuticals, Inc.                                  | CUSIP: 00182C103<br>LEI: 5493000T6CXTND40YH31 | Long             | EC               | CORP              | US        |    129656 | NS      | $9182237.92   | 3.77%             |  |  |  | No            |                  1 | On Loan: —       |
| United Therapeutics Corp.             | United Therapeutics Corp.                                  | CUSIP: 91307C102<br>LEI: 5299005C4HZL4UWROC14 | Long             | EC               | CORP              | US        |     19772 | NS      | $5992695.48   | 2.46%             |  |  |  | No            |                  1 | On Loan: —       |
| Biogen Inc.                           | Biogen Inc.                                                | CUSIP: 09062X103<br>LEI: W8J5WZB5IY3K0NDQT671 | Long             | EC               | CORP              | US        |     49263 | NS      | $5964764.04   | 2.45%             |  |  |  | No            |                  1 | On Loan: No      |
| Travere Therapeutics, Inc.            | Travere Therapeutics, Inc.                                 | CUSIP: 89422G107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    342340 | NS      | $7124095.40   | 2.92%             |  |  |  | No            |                  1 | On Loan: —       |
| Merck & Co., Inc.                     | Merck & Co., Inc.                                          | CUSIP: 58933Y105<br>LEI: 4YV9Y5M8S0BRK1RP0397 | Long             | EC               | CORP              | US        |    141755 | NS      | $12077526.00  | 4.96%             |  |  |  | No            |                  1 | On Loan: No      |
| OmniAb Operations, Inc.               | OmniAb Operations, Inc., Rts., 2027-11-02                  | CUSIP: 68218J202<br>LEI: 5493008K7TB0IKP37H79 | Long             | EC               | CORP              | US        |     39023 | NS      | $0.00         | 0.00%             |  |  |  | No            |                  3 | On Loan: —       |
| Invesco Private Prime Fund            | Invesco Private Prime Fund                                 | CUSIP: N/A<br>LEI: N/A                        | Long             | STIV             | PF                | US        |  39432164 | NS      | $39432163.86  | 16.18%            |  |  |  | No            |                  2 | On Loan: No      |
| Pacira Biosciences, Inc.              | Pacira Biosciences, Inc.                                   | CUSIP: 695127100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    281650 | NS      | $7576385.00   | 3.11%             |  |  |  | No            |                  1 | On Loan: —       |
| Amgen Inc.                            | Amgen Inc.                                                 | CUSIP: 031162100<br>LEI: 62QBXGPJ34PQ72Z12S66 | Long             | EC               | CORP              | US        |     41058 | NS      | $11944593.36  | 4.90%             |  |  |  | No            |                  1 | On Loan: No      |
| Innoviva, Inc.                        | Innoviva, Inc.                                             | CUSIP: 45781M101<br>LEI: 549300ACOX4QTBES6535 | Long             | EC               | CORP              | US        |    392090 | NS      | $7328162.10   | 3.01%             |  |  |  | No            |                  1 | On Loan: —       |
| Harmony Biosciences Holdings, Inc.    | Harmony Biosciences Holdings, Inc.                         | CUSIP: 413197104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    191161 | NS      | $5633514.67   | 2.31%             |  |  |  | No            |                  1 | On Loan: —       |
| Viatris Inc.                          | Viatris Inc.                                               | CUSIP: 92556V106<br>LEI: 254900ZZTSW7NL773X71 | Long             | EC               | CORP              | US        |    615800 | NS      | $5185036.00   | 2.13%             |  |  |  | No            |                  1 | On Loan: No      |
| Invesco Government & Agency Portfolio | Invesco Government & Agency Portfolio, Institutional Class | CUSIP: 825252885<br>LEI: 5493007T1J7WZ5QI1A47 | Long             | STIV             | RF                | US        |    272687 | NS      | $272686.76    | 0.11%             |  |  |  | No            |                  1 | On Loan: No      |
| Johnson & Johnson                     | Johnson & Johnson                                          | CUSIP: 478160104<br>LEI: 549300G0CFPGEF6X2043 | Long             | EC               | CORP              | US        |     78031 | NS      | $12197025.61  | 5.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Pfizer Inc.                           | Pfizer Inc.                                                | CUSIP: 717081103<br>LEI: 765LHXWGK1KXCLTFYQ30 | Long             | EC               | CORP              | US        |    484686 | NS      | $11831185.26  | 4.85%             |  |  |  | No            |                  1 | On Loan: No      |
| Supernus Pharmaceuticals, Inc.        | Supernus Pharmaceuticals, Inc.                             | CUSIP: 868459108<br>LEI: 549300GRM36VBKISYJ58 | Long             | EC               | CORP              | US        |    215467 | NS      | $6998368.16   | 2.87%             |  |  |  | No            |                  1 | On Loan: —       |
| Invesco Private Government Fund       | Invesco Private Government Fund                            | CUSIP: N/A<br>LEI: N/A                        | Long             | STIV             | PF                | US        |  15157838 | NS      | $15157838.50  | 6.22%             |  |  |  | No            |                  2 | On Loan: No      |
| Tarsus Pharmaceuticals, Inc.          | Tarsus Pharmaceuticals, Inc.                               | CUSIP: 87650L103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    171215 | NS      | $8887770.65   | 3.65%             |  |  |  | No            |                  1 | On Loan: —       |
| Amneal Pharmaceuticals, Inc.          | Amneal Pharmaceuticals, Inc.                               | CUSIP: 03168L105<br>LEI: 549300VV176ZO5WQHZ61 | Long             | EC               | CORP              | US        |    831470 | NS      | $6369060.20   | 2.61%             |  |  |  | No            |                  1 | On Loan: No      |
| Liquidia Corp.                        | Liquidia Corp.                                             | CUSIP: 53635D202<br>LEI: 549300O826O5VQJTG707 | Long             | EC               | CORP              | US        |    457562 | NS      | $6392141.14   | 2.62%             |  |  |  | No            |                  1 | On Loan: —       |
| Abbott Laboratories                   | Abbott Laboratories                                        | CUSIP: 002824100<br>LEI: HQD377W2YR662HK5JX27 | Long             | EC               | CORP              | US        |     95410 | NS      | $12474857.50  | 5.12%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2025-05-30

**Name of Applicant:** Invesco Exchange-Traded Fund Trust

**Signature:** Adrien Deberghes

**Name of Signer:** Adrien Deberghes

**Title:** Vice President